Clinical Trial Update: Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial of active specific intranodal immunotherapy using a recombinant vaccinia virus in locally advanced to metastatic melanoma has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Active Specific Intranodal Immunotherapy using Recombinant Vaccinia Virus (recombinant vaccinia virus intranodal immunotherapy)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Melanoma | Phase 1, Phase 2 | Status: COMPLETED